The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients FILE - A sign stands outside the Federal Trade Commission building, Jan. 28, 2015, in Washington. (AP Ph...
July 1, 2024: The cap on Part B payment for new biosimilars. September 1, 2024: The maximum fair price for the first 10 drugs published from CMS that are listed above. January 1, 2025: Medicare Prescription Payment Plan and a $2000 out-of-pocket limit. September 30, 2025: Part B inf...
RELATED:MACPAC calls for Congress to eliminate the drug rebate cap The program requires manufacturers to report to states the “best price” of a drug that is calculated based on the lowest price available to a wholesaler, retailer or provider and the average manufacturer sales price, ...